These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1456740)

  • 21. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):189-222. PubMed ID: 7535318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neocortical cell counts in normal human adult aging.
    Terry RD; DeTeresa R; Hansen LA
    Ann Neurol; 1987 Jun; 21(6):530-9. PubMed ID: 3606042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
    Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
    Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction.
    Scott SA; DeKosky ST; Scheff SW
    Neurology; 1991 Mar; 41(3):351-6. PubMed ID: 2006000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
    Yilmazer-Hanke DM
    Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
    Sebeo J; Hof PR; Perl DP
    Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer's disease.
    Unger JW; Lange W
    Acta Neuropathol; 1992; 83(6):636-46. PubMed ID: 1378987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptides and neuropathology in the amygdala in Alzheimer's disease: relationship between somatostatin, neuropeptide Y and subregional distribution of neuritic plaques.
    Unger JW; McNeill TH; Lapham LL; Hamill RW
    Brain Res; 1988 Jun; 452(1-2):293-302. PubMed ID: 2900051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuron loss and shrinkage in the amygdala in Alzheimer's disease.
    Vereecken TH; Vogels OJ; Nieuwenhuys R
    Neurobiol Aging; 1994; 15(1):45-54. PubMed ID: 8159262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathological study of the amygdala in presenile Alzheimer's disease.
    Tsuchiya K; Kosaka K
    J Neurol Sci; 1990 Dec; 100(1-2):165-73. PubMed ID: 2089133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic atrophy and remodeling of amygdaloid neurons in Alzheimer's disease.
    Scott SA
    Dementia; 1993; 4(5):264-72. PubMed ID: 7505158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neocortical glial cell numbers in Alzheimer's disease. A stereological study.
    Pelvig DP; Pakkenberg H; Regeur L; Oster S; Pakkenberg B
    Dement Geriatr Cogn Disord; 2003; 16(4):212-9. PubMed ID: 14512716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease.
    Boccardi M; Pennanen C; Laakso MP; Testa C; Geroldi C; Soininen H; Frisoni GB
    Neurosci Lett; 2002 Dec; 335(2):139-43. PubMed ID: 12459517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low glial numbers in the amygdala in major depressive disorder.
    Bowley MP; Drevets WC; Ongür D; Price JL
    Biol Psychiatry; 2002 Sep; 52(5):404-12. PubMed ID: 12242056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease and the cerebellum: a morphologic study on neuronal and glial changes.
    Sjöbeck M; Englund E
    Dement Geriatr Cogn Disord; 2001; 12(3):211-8. PubMed ID: 11244215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related variations in the neuron content of the cerebral cortex in senile dementia of Alzheimer type.
    Hubbard BM; Anderson JM
    Neuropathol Appl Neurobiol; 1985; 11(5):369-82. PubMed ID: 4080087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL.
    Blanks JC; Schmidt SY; Torigoe Y; Porrello KV; Hinton DR; Blanks RH
    Neurobiol Aging; 1996; 17(3):385-95. PubMed ID: 8725900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring morphological and cellular changes in Alzheimer's dementia: a review emphasizing stereology.
    Stark AK; Pelvig DP; Jørgensen AM; Andersen BB; Pakkenberg B
    Curr Alzheimer Res; 2005 Oct; 2(4):449-81. PubMed ID: 16248850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebellar dentate nucleus in Alzheimer's disease with myoclonus.
    Fukutani Y; Cairns NJ; Everall IP; Chadwick A; Isaki K; Lantos PL
    Dement Geriatr Cogn Disord; 1999; 10(2):81-8. PubMed ID: 10026380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of neurotensin immunoreactivity in the amygdala in Alzheimer's disease.
    Benzing WC; Mufson EJ; Jennes L; Armstrong DM
    Brain Res; 1990 Dec; 537(1-2):298-302. PubMed ID: 1707731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.